Efficacy of mesenchymal stem cells derived from human adipose tissue in inhibition of hepatocellular carcinoma cells in vitro

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 9, 2012, Pages 606-613

  Zhao, Wenxiu ^a   Ren, Guangli ^a   Zhang, Lei ^a   Zhang, Zhengqi ^a   Liu, Jianming ^a   Kuang, Penghao ^a   Yin, Zhenyu ^a   Wang, Xiaomin ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Adipose derived stem cells; Apoptosis; Conditioned medium; HCC

Indexed keywords

PROTEIN KINASE B;

ADIPOSE DERIVED MESENCHYMAL STEM CELL; ADIPOSE DERIVED STEM CELL; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELLS, CULTURED; CULTURE MEDIA; HUMANS; LIVER NEOPLASMS; MESENCHYMAL STROMAL CELLS;

EID: 84868270067     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.1150     Document Type: Article

References (52)

1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208.
3. Ma T. Mesenchymal stem cells: From bench to bedside. World J Stem Cells 2010;2:13.
4. Zuk PA, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001;7:211.
5. Fraser JK, Zhu M, Wulur I, Alfonso Z. Adipose-derived stem cells. Methods Mol Biol 2008;449:59.
6. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294.
7. Schaffler A, Buchler C. Concise review: Adipose tissuederived stromal cells - basic and clinical implications for novel cell-based therapies. Stem Cells 2007;25:818.
8. Zhao Z, et al. Differentiation of adipose-derived stem cells promotes regeneration of smooth muscle for ureteral tissue engineering. J Surg Res 2012 [Epub ahead of print]; Doi:10.1016/j.jss.2012.01.047.
9. Pecanha R, et al. Adipose-derived stem-cell treatment of skeletal muscle injury. J Bone Joint Surg Am 2012;94:609.
10. Meliga E, Strem BM, Duckers HJ, Serruys PW. Adiposederived cells. Cell Transplant 2007;16:963.
11. Lin G, et al. Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells Dev 2009;18:1399.
12. Erba P, Terenghi G, Kingham PJ. Neural differentiation and therapeutic potential of adipose tissue derived stem cells. Curr Stem Cell Res Ther 2010;5:153.
13. Zavan B, et al. Neural potential of adipose stem cells. Discov Med 2010;10:37.
14. Liang L, et al. Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res 2009;39:822.
15. Fierro FA, Sierralta WD, Epunan MJ, Minguell JJ. Marrowderived mesenchymal stem cells: Role in epithelial tumor cell determination. Clin Exp Metastasis 2004;21:313.
16. Ohlsson LB, Varas L, Kjellman C, et al. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol 2003;75:248.
17. Zhu Y, et al. Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 2009;23:925.
18. Lin G, et al. Effects of transplantation of adipose tissuederived stem cells on prostate tumor. Prostate 2010;70:1066.
19. Razmkhah M, et al. Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma. Cell Immunol 2010;265:80.
20. Razmkhah M, et al. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGFbeta1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response? Cell Immunol 2011;266:116.
21. Cousin B, et al. Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PloS One 2009;4:e6278.
22. Li GC, et al. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci 2010;101:2546.
23. Niess H, et al. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg 2011;254:767; discussion 774.
24. Sun XY, et al. MSCTRAIL-mediated HepG2 cell death in direct and indirect co-cultures. Anticancer Res 2011;31:3705.
25. Zhao W, et al. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Int J Cancer 2011;129:2651.
26. Noel D, et al. Cell specific differences between human adiposederived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008;314:1575.
27. Mizuno H, Tobita M, Uysal AC. Concise reviewadiposederived stem cells as a novel tool for future regenerative medicine. Stem Cells 2012;30:804.
28. Zimmerlin L, et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry Part A 2010;77:22.
29. Bailey AM, Kapur S, Katz AJ. Characterization of adiposederived stem cells: An update. Curr Stem Cell Res Ther 2010;5:95.
30. Zimmerlin L, et al. Regenerative therapy and cancer: In vitro and in vivo studies of the interaction between adiposederived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011;17:93.
31. Prantl L, et al. Adipose tissue-derived stem cells promote prostate tumor growth. Prostate 2010;70:1709.
32. Casteilla L, Planat-BenardV, Laharrague P, Cousin B.Adiposederived stromal cells: Their identity and uses in clinical trials, an update. World J Stem Cells 2011;3:25.
33. Zhang Y, Bellows CF, Kolonin MG. Adipose tissue-derived progenitor cells and cancer. World J Stem Cells 2010;2:103.
34. Zhang Y, et al. White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res 2009;69:5259.
35. Sun B, et al. Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow. Stem Cells Dev 2005; 14:292.
36. Karnoub AE, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557.
37. Khakoo AY, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006;203:1235.
38. Chen YL, Law PY, Loh HH. Inhibition of PI3K/Akt signaling: An emerging paradigm for targeted cancer therapy. Curr Med Chem Anti-cancer Agents 2005;5:575.
39. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 2010;29:4989.
40. Nakanishi K, Sakamoto M, Yamasaki S, et al. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 2005; 103:307.
41. Boyault S, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007;45:42.
42. Hursting SD, Nunez NP, Varticovski L, Vinson C. The obesity-cancer link: Lessons learned from a fatless mouse. Cancer Res 2007;67:2391.
43. Charbord P, Casteilla L. [Human mesenchymal stem cell biology]. Med Sci 2011;27:261.
44. Rehman J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004; 109:1292.
45. Carnero A. The PKB/AKT pathway in cancer. Curr Pharm Des 2010;16:34.
46. Sahin F, et al. mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res 2004;10:8421.
47. Cardone MH, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998;282:1318.
48. Zhang HM, et al. Akt kinase activation blocks apoptosis in intestinal epithelial cells by inhibiting caspase-3 after polyamine depletion. J Biol Chem 2004;279:22539.
49. Asselin E, Mills GB, Tsang BK. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res 2001;61:1862.
50. Bratton MR, et al. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: Implications for breast cancer cell survival. Int J Oncol 2010;37:541.
51. Zolochevska O, Yu G, Gimble JM, Figueiredo ML. Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adiposederived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth. Stem Cells Dev 2012; 21:1112.
52. Grisendi G, et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosisinducing ligand delivery for cancer therapy. Cancer Res 2010;70:3718.